Catheter Precision Secures $4.9 Million Through Warrant Exercises

Catheter Precision, Inc., a U.S. medical device company, has announced a definitive agreement for the exercise of multi-series warrants. The exercise involves Series E, F, G, H, and I warrants, leading to the acquisition of up to 5,347,981 shares at a reduced price of $0.70, generating approximately $3.7 million in gross proceeds. Additionally, $1,185,000 was gained from recent warrant exercises, resulting in total proceeds of $4.9 million.

The exercise process was facilitated by Ladenburg Thalmann & Co. Inc., serving as the warrant inducement agent. In return, Catheter Precision will issue Series K warrants, allowing for the purchase of up to 10,695,962 shares. These will also be priced at $0.70 and carry a term of 5.5 years, pending shareholder approval.

Further details will be provided in a forthcoming Form 8-K filed with the SEC.